Syngene slips to a Q1 net loss as revenue falls 16% YoY; transition year begins weak

Syngene International posted a consolidated net loss of ₹9.0 Cr for Q1 FY27 (quarter ended 30 June 2026), swinging from an ₹86.7 Cr profit a year earlier and ₹147.9 Cr in the March quarter. Revenue from operations fell to ₹736.0 Cr, down 15.8% YoY and 29.0% sequentially — the softest print in years — dragging basic EPS to -₹0.22 from +₹2.16.

Three pressures stacked up on the bottom line: revenue deleverage from the Librela contract destocking, a ₹50.1 Cr net foreign-exchange loss (versus just ₹4.8 Cr a year ago), and a ₹13.5 Cr exceptional charge for employee termination benefits (note 11). Crucially, even before the exceptional item, profit before tax was still a ₹5.7 Cr loss — so this is a genuinely weak operating quarter, not merely one-off optics. Net margin fell to -1.2% from +9.7% YoY, and the EBITDA margin dropped well below the mid-20s the company has guided for; a ₹10.2 Cr tax credit only partly cushioned the result.

The stock went into the print at ₹414.25, down 5.7% over the past month of trading.

Standalone also loss-making — net loss ₹2.1 Cr (EPS -₹0.05) on revenue of ₹663.0 Cr

The weakness is exactly what management flagged on the April (Q4 FY26) concall: a cautious, bearish tone and an explicit warning of a weak first half of FY27 from Librela destocking, with FY27 framed as a "transition year" targeting broadly flat revenue and mid-20s EBITDA margins before a FY28 recovery. On that low bar the revenue drop is on-script, but the swing to a loss and the sub-20s margin sit at the weaker end of expectations; no formal Street consensus figure for the quarter is on record. The print also lands amid unusual management churn — MD & CEO Peter Bains resigned (July 3), the General Counsel is departing (July 15), and a subsidiary's auditor resigned (July 8) — while the board is voluntarily liquidating subsidiary SMSL.